Please login to the form below

Not currently logged in
Email:
Password:

Icon promotes Brendan Buckley to chief medical officer

In his new role he will serve as the CRO's lead medical expert

Icon Brendan BuckleyDublin-based clinical research organisation (CRO) Icon has promoted Professor Brendan Buckley to chief medical officer.

Prof Buckley joined the company as its 2011 acquisition of clinical trechnology firm Firecrest Clinical, which he co-founded and where he was senior vice president of medical affairs. 

In his new role, which will see him join the company's executive leadership team, he will serve as Icon's lead medical expert, representing the company's position on key scientific, ethical and medical governance matters.

He will also be tasked with providing guidance and oversight to company's medical and scientific groups.

Icon's CEO Ciaran Murray said: “Brendan's wealth of experience both as an advisor to European regulatory agencies and a physician with over 30 years of clinical trial experience, will help us advance our clients' products through their development pipelines and ensure Icon studies continue to be performed to the highest scientific and ethical standards.”

An endocrinologist with over 30 years' experience, Prof Buckley has been a board member of the Irish Medicines Board and of the European Medical Agency's (EMA) Scientific Advisory Group for Diabetes and Endocrinology since 2005.

Brendan is Clinical Professor of Medicine and Pharmacology at the School of Medicine, University College Cork (UCC), Ireland, and also chairs several independent Data and Safety Monitoring Boards for medium to large cardio-metabolic and rare disease clinical studies.

2nd July 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics